Establishing the characteristics of an effective pharmacogenetic test for clozapine-induced agranulocytosis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Establishing the characteristics of an effective pharmacogenetic test for clozapine-induced agranulocytosis
Authors
Keywords
-
Journal
PHARMACOGENOMICS JOURNAL
Volume 15, Issue 5, Pages 461-466
Publisher
Springer Nature
Online
2015-03-03
DOI
10.1038/tpj.2015.5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clozapine: a review of clinical practice guidelines and prescribing trends
- (2014) Stephanie Warnez et al. BMC Psychiatry
- Mortality, attempted suicide, re-hospitalisation and prescription refill for clozapine and other antipsychotics in Sweden-a register-based study
- (2014) Gunilla Ringbäck Weitoft et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Clozapine-induced agranulocytosis is associated with rare HLA-DQB1 and HLA-B alleles
- (2014) Jacqueline I. Goldstein et al. Nature Communications
- Imputation of TPMT defective alleles for the identification of patients with high-risk phenotypes
- (2014) Berta Almoguera et al. Frontiers in Genetics
- Opening Pandora’s box in the UK: a hypothetical pharmacogenetic test for clozapine
- (2013) Benjamin WJ Spencer et al. PHARMACOGENOMICS
- Antipsychotics and mortality in first-onset schizophrenia: Prospective Finnish register study with 5-year follow-up
- (2013) Marjo Kiviniemi et al. SCHIZOPHRENIA RESEARCH
- Medication and suicide risk in schizophrenia: A nested case–control study
- (2013) Johan Reutfors et al. SCHIZOPHRENIA RESEARCH
- Clozapine-Induced Agranulocytosis in Finland, 1982–2007
- (2012) Liisa Lahdelma et al. JOURNAL OF CLINICAL PSYCHIATRY
- Beyond White Blood Cell Monitoring
- (2012) Dan Cohen et al. JOURNAL OF CLINICAL PSYCHIATRY
- Clozapine-induced leukopenia: arguments for rechallenge
- (2011) J. P. A. M. Bogers et al. IRISH JOURNAL OF MEDICAL SCIENCE
- When can patients with potentially life-threatening adverse effects be rechallenged with clozapine? A systematic review of the published literature
- (2011) Peter Manu et al. SCHIZOPHRENIA RESEARCH
- Genetics of Antipsychotic-induced Side Effects and Agranulocytosis
- (2011) Nabilah I. Chowdhury et al. Current Psychiatry Reports
- Candidate Gene Analysis Identifies a Polymorphism inHLA-DQB1Associated With Clozapine-Induced Agranulocytosis
- (2010) Maria C. Athanasiou et al. JOURNAL OF CLINICAL PSYCHIATRY
- Clozapine: a distinct, poorly understood and under-used molecule
- (2010) Ridha Joober JOURNAL OF PSYCHIATRY & NEUROSCIENCE
- 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)
- (2009) Jari Tiihonen et al. LANCET
- HLA-B*5701 Screening for Hypersensitivity to Abacavir
- (2008) Simon Mallal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clozapine-induced agranulocytosis and its genetic determinants
- (2008) Carolin Opgen-Rhein et al. PHARMACOGENOMICS
- Carbamazepine,HLA-B*1502and risk of Stevens–Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations
- (2008) P Brent Ferrell et al. PHARMACOGENOMICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started